Top investors say Puma Biotechnology Inc (PBYI) ticks everything they need

With 0.51 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.42 shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $5.79 whereas the lowest price it dropped to was $5.40. The 52-week range on PBYI shows that it touched its highest point at $5.67 and its lowest point at $2.13 during that stretch. It currently has a 1-year price target of $4.67. Beta for the stock currently stands at 1.27.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of PBYI was up-trending over the past week, with a rise of 22.46%, but this was up by 21.05% over a month. Three-month performance surged to 82.91% while six-month performance rose 43.42%. The stock gained 25.11% in the past year, while it has gained 33.49% so far this year. A look at the trailing 12-month EPS for PBYI yields 0.07 with Next year EPS estimates of 0.31.

Float and Shares Shorts:

At present, 41.18 million PBYI shares are outstanding with a float of 37.00 million shares on hand for trading. On Jan 31, 2024, short shares totaled 3.21 million, which was 6.74% higher than short shares on Dec 29, 2023. In addition to PBYI as the firm’s Puma Biotechnology Inc, PBI serves as its Pitney Bowes Inc..

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for PBYI since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With PBYI analysts setting a high price target of $8.00 and a low target of $2.00, the average target price over the next 12 months is $4.67. Based on these targets, PBYI could surge 38.41% to reach the target high and fall by -65.4% to reach the target low. Reaching the average price target will result in a decline of -19.2% from current levels.

Summary of Insider Activity:

Insiders traded PBYI stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 7 while that of sell transactions has risen to 13 over the past year. The total number of shares bought during that period was 189,000 while 236,897 shares were sold.